LAIR1 Matched Antibody Pair (679) (APMAB-679LY)

Lovewell, R. R., Hong, J., Kundu, S., Fielder, C. M., Hu, Q., Kim, K. W., ... & Kim, T. K. (2023). LAIR-1 agonism as a therapy for acute myeloid leukemia. Journal of Clinical Investigation, 133(22), e169519.

Son, M. (2022). Understanding the contextual functions of C1q and LAIR-1 and their applications. Experimental & Molecular Medicine, 54(5), 567-572.

Helou, D. G., Shafiei-Jahani, P., Hurrell, B. P., Painter, J. D., Quach, C., Howard, E., & Akbari, O. (2022). LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity. Journal of Allergy and Clinical Immunology, 149(1), 223-236.

Horn, L. A., Chariou, P. L., Gameiro, S. R., Qin, H., Iida, M., Fousek, K., ... & Palena, C. (2022). Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1–mediated tumor eradication. The Journal of clinical investigation, 132(8).

Peng, D. H., Rodriguez, B. L., Diao, L., Chen, L., Wang, J., Byers, L. A., ... & Gibbons, D. L. (2020). Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion. Nature communications, 11(1), 4520.

Liu, Y., Ma, L., Shangguan, F., Zhao, X., Wang, W., Gao, Z., ... & Cao, Q. (2020). LAIR-1 suppresses cell growth of ovarian cancer cell via the PI3K-AKT-mTOR pathway. Aging (Albany NY), 12(16), 16142.

Guo, N., Zhang, K., Gao, X., Lv, M., Luan, J., Hu, Z., ... & Gou, X. (2020). Role and mechanism of LAIR-1 in the development of autoimmune diseases, tumors, and malaria: a review. Current Research in Translational Medicine, 68(3), 119-124.

Kumawat, K., Geerdink, R. J., Hennus, M. P., Roda, M. A., Van Ark, I., Leusink-Muis, T., ... & Meyaard, L. (2019). LAIR-1 limits neutrophilic airway inflammation. Frontiers in immunology, 10, 842.

Wu, X., Zhang, L., Zhou, J., Liu, L., Fu, Q., Fu, A., ... & Xue, J. (2019). Clinicopathologic significance of LAIR-1 expression in hepatocellular carcinoma. Current problems in cancer, 43(1), 18-26.

Jin, J., Wang, Y., Ma, Q., Wang, N., Guo, W., Jin, B., ... & Chen, L. (2018). LAIR-1 activation inhibits inflammatory macrophage phenotype in vitro. Cellular Immunology, 331, 78-84.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Alternative Versions

LAIR1 Matched Antibody Pair (678)

Antibody Pairs

LAIR1 Matched Antibody Pair (678)

Related Products

Mouse Anti-LAIR1 Recombinant Antibody (CBWJC-2316)

Mouse Anti-LAIR1 Recombinant Antibody (7H26)

Mouse Anti-LAIR1 Recombinant Antibody (CBYJL-1059)

Human Anti-LAIR1 Recombinant Antibody (CBXC-0850)

Hamster Anti-Lair1 Recombinant Antibody (CBYJL-2417)

Mouse Anti-LAIR1 Recombinant Antibody (CBYJL-1066)

Armenian Hamster Anti-Lair1 Recombinant Antibody (113)

Mouse Anti-LAIR1 Recombinant Antibody (CBYJL-1061)

Mouse Anti-LAIR1 Recombinant Antibody (lc12)

Recombinant Mouse Anti-LAIR1 Antibody (CBHb364)

Isotype control